GEN Exclusives

More »

GEN News Highlights

More »
Oct 2, 2013

AAIPharma Merges with Cambridge Major Laboratories

  • Chemistry outsourcing firm Cambridge Major Laboratories (CML) is merging with contract services company AAIPharma Services with the aim of forming the premier global supplier of integrated CMC services. The merger is expected to close by the end of October.

    Patrick Walsh, CEO of AAIPharma Services, said in a statement that the new combined organization will provide services including process chemistry, solid-state chemistry, API manufacturing, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid and sterile), packaging, and stability services.

    “The basis for the merger was to start with the right building blocks—a merger of two equals: two highly respected, market-leading firms with proven expertise in API development, analytical chemistry, and finished dosage forms,” said Brian Scanlan, CEO & president of CML. “We believe that we have a strong foundation to deliver superior customer-oriented solutions to expedite drug development and commercialization.”

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »